What is Home Bancshares's earnings per share (EPS)?

Home Bancshares (HOMB) reported diluted earnings per share of $2.41 for fiscal year 2025. This represents a 19.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Home Bancshares Financials

HOMB

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Home Bancshares (HOMB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HOMB FY2025 2026-05-05

Higher earnings on a mostly unchanged asset base show this bank's recent improvement came from better spread economics, not expansion.

In FY2025, earnings improved without balance-sheet expansion: revenue slipped to $1.3B while interest expense fell to $386M. That combination lifted net margin to 37.2% and ROA to 2.1%, suggesting the year was driven more by better funding economics than by adding assets.

From FY2021 to FY2025, debt-to-equity moved from 5.5x to 4.3x even as assets stayed near $22.9B. Because equity rose to $4.3B, a similar-sized balance sheet now sits on a thicker capital base, which helps explain why ROE at 11.1% did not rise as much as profit did.

The reported cash profile is cash-generative and lightly capital-intensive: operating cash flow was $399M and capex only $22M in FY2025. With free cash flow at $377M, the combined dividend and buyback outlay of about $241M was covered internally rather than requiring external funding.

Financial Health Signals

Financial Health Score 53/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Home Bancshares's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Capital

Credit Quality

Stability

Piotroski F-Score Partial

4/6

Home Bancshares passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.84x

For every $1 of reported earnings, Home Bancshares generates $0.84 in operating cash flow ($399.3M OCF vs $475.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.3B

YoY-1.6%

5Y CAGR+13.6%

10Y CAGR+13.0%

Home Bancshares generated $1.3B in revenue in fiscal year 2025. This represents a decrease of 1.6% from the prior year.

EBITDA

N/A

Net Income

$475.4M

YoY+18.2%

5Y CAGR+17.3%

10Y CAGR+13.2%

Home Bancshares reported $475.4M in net income in fiscal year 2025. This represents an increase of 18.2% from the prior year.

EPS (Diluted)

$2.41

YoY+19.9%

5Y CAGR+13.1%

10Y CAGR+9.1%

Home Bancshares earned $2.41 per diluted share (EPS) in fiscal year 2025. This represents an increase of 19.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$377.0M

YoY-10.7%

5Y CAGR+6.1%

10Y CAGR+6.8%

Home Bancshares generated $377.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 10.7% from the prior year.

Cash & Debt

$667.3M

YoY-26.7%

5Y CAGR-12.0%

10Y CAGR+10.1%

Home Bancshares held $667.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.81

YoY+7.3%

5Y CAGR+8.7%

10Y CAGR+11.3%

Home Bancshares paid $0.81 per share in dividends in fiscal year 2025. This represents an increase of 7.3% from the prior year.

Shares Outstanding

196M

YoY-1.3%

5Y CAGR+3.5%

10Y CAGR+3.4%

Home Bancshares had 196M shares outstanding in fiscal year 2025. This represents a decrease of 1.3% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

37.2%

YoY+6.2pp

5Y CAGR+5.5pp

10Y CAGR+0.6pp

Home Bancshares's net profit margin was 37.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.2 percentage points from the prior year.

Return on Equity

11.1%

YoY+0.9pp

5Y CAGR+2.8pp

10Y CAGR-0.5pp

Home Bancshares's ROE was 11.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$82.2M

YoY-4.9%

5Y CAGR+26.2%

10Y CAGR+44.9%

Home Bancshares spent $82.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 4.9% from the prior year.

Capital Expenditures

$22.3M

YoY-42.2%

5Y CAGR+14.0%

10Y CAGR+7.8%

Home Bancshares invested $22.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 42.2% from the prior year.

HOMB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.3B-1.6%	$1.3B+10.6%	$1.2B+33.9%	$877.8M+40.4%	$625.2M-7.5%	$676.0M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$252.9M+4.9%	$241.0M-6.2%	$257.0M+7.6%	$238.9M+39.9%	$170.8M+4.2%	$163.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$386.5M-14.3%	$451.0M+29.6%	$348.1M+192.3%	$119.1M+128.1%	$52.2M-44.1%	$93.4M
Income Tax	$136.4M+13.5%	$120.1M+1.0%	$119.0M+33.2%	$89.3M-8.6%	$97.8M+54.5%	$63.3M
Net Income	$475.4M+18.2%	$402.2M+2.4%	$392.9M+28.7%	$305.3M-4.3%	$319.0M+48.8%	$214.4M
EPS (Diluted)	$2.41+19.9%	$2.01+3.6%	$1.94+23.6%	$1.57-19.1%	$1.94+49.2%	$1.30

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$311.0M-3.9%	$323.6M0.0%	$323.5M+1.4%	$319.1M+2.1%	$312.5M-3.2%	$322.7M-3.0%	$332.8M+1.7%	$327.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$63.2M+0.5%	$62.9M-1.4%	$63.8M-0.8%	$64.3M+4.0%	$61.9M+1.7%	$60.8M+3.3%	$58.9M-2.6%	$60.4M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$87.1M-5.4%	$92.0M-5.5%	$97.4M-1.8%	$99.2M+1.3%	$97.9M-7.3%	$105.6M-10.2%	$117.6M+1.9%	$115.5M
Income Tax	$34.0M-3.1%	$35.1M-1.7%	$35.7M+6.4%	$33.6M+5.1%	$31.9M+10.6%	$28.9M-0.5%	$29.0M-8.9%	$31.9M
Net Income	$118.2M0.0%	$118.2M-4.4%	$123.6M+4.4%	$118.4M+2.8%	$115.2M+14.6%	$100.6M+0.5%	$100.0M-1.5%	$101.5M
EPS (Diluted)	$0.60	N/A	$0.63+5.0%	$0.60+3.4%	$0.58	N/A	$0.50-2.0%	$0.51

HOMB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$22.9B+1.7%	$22.5B-0.7%	$22.7B-1.0%	$22.9B+26.8%	$18.1B+10.1%	$16.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$667.3M-26.7%	$910.3M-9.0%	$1.0B+38.0%	$724.8M-80.1%	$3.7B+188.8%	$1.3B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B+43.7%	$973.0M0.0%	$973.0M
Total Liabilities	$18.6B+0.3%	$18.5B-1.8%	$18.9B-2.5%	$19.4B+26.6%	$15.3B+10.8%	$13.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.3B+8.5%	$4.0B+4.5%	$3.8B+7.5%	$3.5B+27.5%	$2.8B+6.1%	$2.6B
Retained Earnings	$2.3B+16.3%	$1.9B+14.9%	$1.7B+17.1%	$1.4B+14.0%	$1.3B+21.8%	$1.0B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$23.2B+1.4%	$22.9B+0.8%	$22.7B-0.9%	$22.9B-0.4%	$23.0B+2.2%	$22.5B-1.5%	$22.8B-0.4%	$22.9B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.1B+66.6%	$667.3M-16.7%	$800.9M-27.3%	$1.1B-15.0%	$1.3B+42.3%	$910.3M-10.5%	$1.0B-3.9%	$1.1B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B
Total Liabilities	$18.9B+1.4%	$18.6B+0.5%	$18.5B-1.7%	$18.8B-0.7%	$18.9B+2.3%	$18.5B-1.8%	$18.9B-1.1%	$19.1B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.3B+1.2%	$4.3B+1.9%	$4.2B+3.2%	$4.1B+1.1%	$4.0B+2.1%	$4.0B0.0%	$4.0B+2.7%	$3.9B
Retained Earnings	$2.3B+3.4%	$2.3B+3.5%	$2.2B+4.0%	$2.1B+3.9%	$2.0B+3.9%	$1.9B+3.3%	$1.9B+3.4%	$1.8B

HOMB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$399.3M-13.3%	$460.6M+21.3%	$379.7M-8.1%	$413.2M+6.1%	$389.4M+33.5%	$291.7M
Capital Expenditures	$22.3M-42.2%	$38.5M+71.5%	$22.5M+14.7%	$19.6M+90.4%	$10.3M-11.0%	$11.5M
Free Cash Flow	$377.0M-10.7%	$422.1M+18.2%	$357.2M-9.2%	$393.6M+3.8%	$379.1M+35.3%	$280.2M
Investing Cash Flow	-$470.3M-8399.2%	$5.7M-99.0%	$578.5M+156.5%	-$1.0B-264.0%	$624.7M+195.8%	-$651.9M
Financing Cash Flow	-$172.0M+69.1%	-$556.2M+18.5%	-$682.7M+70.5%	-$2.3B-268.6%	$1.4B+21.1%	$1.1B
Dividends Paid	$158.9M+5.9%	$150.0M+2.8%	$145.9M+13.6%	$128.4M+39.4%	$92.1M+5.1%	$87.7M
Share Buybacks	$82.2M-4.9%	$86.5M+77.3%	$48.8M-31.2%	$70.9M+59.3%	$44.5M+73.1%	$25.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$150.8M+70.0%	$88.7M-23.0%	$115.2M+46.9%	$78.4M-33.0%	$117.0M+55.8%	$75.1M-41.6%	$128.6M+17.6%	$109.4M
Capital Expenditures	$11.6M+159.2%	$4.5M+53.3%	$2.9M-63.6%	$8.0M+16.2%	$6.9M-51.7%	$14.3M+15.2%	$12.4M+21.1%	$10.2M
Free Cash Flow	$139.3M+65.3%	$84.2M-25.0%	$112.2M+59.4%	$70.4M-36.1%	$110.1M+81.0%	$60.9M-47.7%	$116.2M+17.2%	$99.2M
Investing Cash Flow	$89.0M+132.0%	-$277.9M-431.5%	-$52.3M+36.6%	-$82.5M-43.3%	-$57.6M-142.8%	$134.6M+28.8%	$104.5M+150.1%	-$208.5M
Financing Cash Flow	$204.7M+267.9%	$55.6M+115.3%	-$363.0M-90.5%	-$190.5M-158.5%	$325.9M+202.8%	-$317.1M-15.7%	-$274.2M-1472.0%	-$17.4M
Dividends Paid	$41.3M+0.1%	$41.3M+4.7%	$39.4M-0.2%	$39.5M+1.9%	$38.8M0.0%	$38.8M-0.3%	$38.9M+7.7%	$36.1M
Share Buybacks	$13.9M-6.8%	$14.9M+48.7%	$10.0M-63.5%	$27.5M-7.8%	$29.8M+1113.5%	$2.5M-90.9%	$27.0M-17.9%	$32.9M

HOMB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	37.2%+6.2pp	30.9%-2.5pp	33.4%-1.3pp	34.8%-16.2pp	51.0%+19.3pp	31.7%
Return on Equity	11.1%+0.9pp	10.2%-0.2pp	10.4%+1.7pp	8.7%-2.9pp	11.5%+3.3pp	8.2%
Return on Assets	2.1%+0.3pp	1.8%+0.1pp	1.7%+0.4pp	1.3%-0.4pp	1.8%+0.5pp	1.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	4.33-0.4	4.68-0.3	4.98-0.5	5.49-0.0	5.53+0.2	5.29
FCF Margin	29.5%-3.0pp	32.5%+2.1pp	30.4%-14.4pp	44.8%-15.8pp	60.6%+19.2pp	41.4%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	38.0%+1.5pp	36.5%-1.7pp	38.2%+1.1pp	37.1%+0.2pp	36.9%+5.7pp	31.2%+1.1pp	30.1%-1.0pp	31.0%
Return on Equity	2.7%-0.0pp	2.8%-0.2pp	2.9%+0.0pp	2.9%+0.1pp	2.9%+0.3pp	2.5%0.0pp	2.5%-0.1pp	2.6%
Return on Assets	0.5%0.0pp	0.5%-0.0pp	0.5%+0.0pp	0.5%+0.0pp	0.5%+0.1pp	0.4%0.0pp	0.4%0.0pp	0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	4.330.0	4.33-0.1	4.39-0.2	4.61-0.1	4.690.0	4.68-0.1	4.76-0.2	4.94
FCF Margin	44.8%+18.7pp	26.0%-8.7pp	34.7%+12.6pp	22.1%-13.2pp	35.2%+16.4pp	18.9%-16.1pp	34.9%+4.6pp	30.3%

Similar Companies

Bank Ozk OZK

$5.5B

Valley Natl Bancorp VLY

$8.1B

F N B Corp FNB

$6.7B

Glacier Bancorp Inc GBCI

$6.7B

Hancock Whitney Corporation HWC

$6.1B

Frequently Asked Questions

What is Home Bancshares's annual revenue?

Home Bancshares (HOMB) reported $1.3B in total revenue for fiscal year 2025. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Home Bancshares's revenue growing?

Home Bancshares (HOMB) revenue declined by 1.6% year-over-year, from $1.3B to $1.3B in fiscal year 2025.

Is Home Bancshares profitable?

Yes, Home Bancshares (HOMB) reported a net income of $475.4M in fiscal year 2025, with a net profit margin of 37.2%.

What is Home Bancshares's net profit margin?

Home Bancshares (HOMB) had a net profit margin of 37.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Home Bancshares pay dividends?

Yes, Home Bancshares (HOMB) paid $0.81 per share in dividends during fiscal year 2025.

What is Home Bancshares's return on equity (ROE)?

Home Bancshares (HOMB) has a return on equity of 11.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Home Bancshares's free cash flow?

Home Bancshares (HOMB) generated $377.0M in free cash flow during fiscal year 2025. This represents a -10.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Home Bancshares's operating cash flow?

Home Bancshares (HOMB) generated $399.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Home Bancshares's total assets?

Home Bancshares (HOMB) had $22.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Home Bancshares's capital expenditures?

Home Bancshares (HOMB) invested $22.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Home Bancshares buy back shares?

Yes, Home Bancshares (HOMB) spent $82.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Home Bancshares have outstanding?

Home Bancshares (HOMB) had 196M shares outstanding as of fiscal year 2025.

What is Home Bancshares's debt-to-equity ratio?

Home Bancshares (HOMB) had a debt-to-equity ratio of 4.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Home Bancshares's return on assets (ROA)?

Home Bancshares (HOMB) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Home Bancshares's Piotroski F-Score?

Home Bancshares (HOMB) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Home Bancshares's earnings high quality?

Home Bancshares (HOMB) has an earnings quality ratio of 0.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Home Bancshares?

Home Bancshares (HOMB) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.